AMBER SAPP: Open Payments
NPI 1568715340 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,764 in 87 payments from 19 companies in 2025. Trend: 2023 $1,064 · 2024 $1,813 · 2025 $1,764
Food & beverage: $1,764
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $236 |
| GlaxoSmithKline, LLC. | 14 | $232 |
| AstraZeneca Pharmaceuticals LP | 9 | $185 |
| Regeneron Healthcare Solutions, Inc. | 10 | $172 |
| GENZYME CORPORATION | 4 | $143 |
| Insmed, Inc. | 5 | $126 |
| Merck Sharp & Dohme LLC | 5 | $118 |
| Verona Pharma, Inc. | 4 | $113 |
| United Therapeutics Corporation | 4 | $108 |
| Grifols USA, LLC | 2 | $64 |
Products named: DUPIXENT, TRELEGY ELLIPTA, OFEV, Arikayce, WINREVAIR, Ohtuvayre, AIRSUPRA, Tyvaso.
Industry payments across GA — which companies pay providers there.
